Piramal Pharma is approaching the next few months with “cautious optimism”, given the geopolitical uncertainty and directives from the new administration in the United States. Customers ...

Piramal Pharma Ltd share price was down by -1.50% from the previous closing price of ₹232.90. Who are peers of Piramal Pharma Ltd? The peers of Piramal Pharma Ltd are Sun Pharmaceuticals ...

Several top brokerage firms have expressed their positive views on the Piramal Pharma stock in the recent past. In January's first week, global brokerage firm Jefferies raised its target price for ...

What will also help Piramal Pharma is the anticipation of a recovery in the US biotech sector in H2FY25, the JM Financial note said. SEBI’s review order by a whole-time member has exonerated ...

Piramal Pharma Limited said, "FY25 so far has been a steady year for the Company with revenue growth of 14% and EBITDA growing at 20%. Our CDMO business continues to deliver robust performance ...

Stock Market Today: Piramal Pharma share price gained more than 8% in intraday trades on Wednesday. Piramal Pharma share ...

Shares of Piramal Pharma jumped 1.24 per cent and closed at Rs 252.20 apiece, on Monday. The stock registered a high of Rs 254.70 and a low of Rs 245.85. More than 43.60 lakh equity shares changed ...

As of late morning trading, the shares were up 7.7 per cent at Rs 238.55 apiece. Piramal Pharma had previously declined 12 per cent over the last three sessions and is down 10 per cent so far in ...

Piramal Pharma Limited will be hosting a conference call for investors / analysts on 29th January 2025 from 5:30 PM to 6:15 ...

Piramal Pharma Limited (PPL, NSE: PPLPHARMA I BSE: 543635), offers a portfolio of differentiated products and services through its 17 * global development and manufacturing facilities and a global ...